http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 05 Jun 2026 12:57:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html si-local-file:///var/storage/secattach/20260605/26610062.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html Fri, 05 Jun 2026 12:57:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html si-local-file:///var/storage/secattach/20260605/26610062.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html Fri, 05 Jun 2026 12:57:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html si-local-file:///var/storage/secattach/20260529/26576467.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html Fri, 29 May 2026 17:10:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html si-local-file:///var/storage/secattach/20260529/26576467.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html Fri, 29 May 2026 17:10:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html si-local-file:///var/storage/secattach/20260529/26576388.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html si-local-file:///var/storage/secattach/20260529/26576388.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html si-local-file:///var/storage/secattach/20260529/26576389.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html si-local-file:///var/storage/secattach/20260529/26576389.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html si-local-file:///var/storage/secattach/20260529/26576390.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html si-local-file:///var/storage/secattach/20260529/26576390.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html si-local-file:///var/storage/secattach/20260529/26576391.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html si-local-file:///var/storage/secattach/20260529/26576391.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html si-local-file:///var/storage/secattach/20260529/26576396.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html si-local-file:///var/storage/secattach/20260529/26576396.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html si-local-file:///var/storage/secattach/20260529/26576399.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html si-local-file:///var/storage/secattach/20260529/26576399.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html si-local-file:///var/storage/secattach/20260529/26576400.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html si-local-file:///var/storage/secattach/20260529/26576400.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html si-local-file:///var/storage/secattach/20260529/26576401.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html si-local-file:///var/storage/secattach/20260529/26576401.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Morris+Gabriel+S/26576402.html si-local-file:///var/storage/secattach/20260529/26576402.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Morris+Gabriel+S/26576402.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Morris+Gabriel+S/26576402.html si-local-file:///var/storage/secattach/20260529/26576402.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Morris+Gabriel+S/26576402.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/Analyst+PT+Change/Immix+Biopharma%2C+Inc.++%28IMMX%29+PT+Raised+to+%2420+at+H.C.+Wainwright/26545554.html (Updated - May 26, 2026 6:52 AM EDT) <p>H.C. Wainwright analyst Robert Burns raised the price target on Immix Biopharma, Inc. (NASDAQ: IMMX) to $20.00 (from $15.00) while maintaining a Buy rating.</p><p>The analyst commented: "Yesterday, Immix announced that the four r/r AL amyloidosis patients in the Phase 2 NEXICART-2 trial who were MRD-negative but not yet evaluable for efficacy at the time of the ASH 2025 presentation have now achieved complete response. With these additional responses, the hematologic CR rate for NXC-201 has increased to 95% (19/20; 4 median prior Rx), up from 75% (15/20) reported at ASH 2025 (see Figure http://www.streetinsider.com/Analyst+PT+Change/Immix+Biopharma%2C+Inc.++%28IMMX%29+PT+Raised+to+%2420+at+H.C.+Wainwright/26545554.html Tue, 26 May 2026 06:52:20 -0400 IMMX http://www.streetinsider.com/Analyst+Comments/Immix+Biopharma%2C+Inc.++%28IMMX%29+PT+Raised+to+%2420+at+H.C.+Wainwright/26545554.html (Updated - May 26, 2026 6:52 AM EDT) <p>H.C. Wainwright analyst Robert Burns raised the price target on Immix Biopharma, Inc. (NASDAQ: IMMX) to $20.00 (from $15.00) while maintaining a Buy rating.</p><p>The analyst commented: "Yesterday, Immix announced that the four r/r AL amyloidosis patients in the Phase 2 NEXICART-2 trial who were MRD-negative but not yet evaluable for efficacy at the time of the ASH 2025 presentation have now achieved complete response. With these additional responses, the hematologic CR rate for NXC-201 has increased to 95% (19/20; 4 median prior Rx), up from 75% (15/20) reported at ASH 2025 (see Figure http://www.streetinsider.com/Analyst+Comments/Immix+Biopharma%2C+Inc.++%28IMMX%29+PT+Raised+to+%2420+at+H.C.+Wainwright/26545554.html Tue, 26 May 2026 06:52:20 -0400 IMMX http://www.streetinsider.com/Equity+Offerings/Immix+Biopharma+closes+%24150+million+stock+offering/26542843.html <p>Immix Biopharma Inc. (NASDAQ: IMMX) announced the completion of an underwritten public offering that raised approximately $140.65 million in net proceeds. The company sold 16,778,524 shares of common stock at $8.94 per share.</p> <p>The biotechnology company said the financing included participation from leading U.S. biotechnology institutional investors and mutual funds. Morgan Stanley served as lead book-running manager, with BofA Securities acting as book-running manager. LifeSci Capital, Mizuho and Needham & Company served as co-lead managers.</p> <p>The securities were offered through a shelf registration statement filed with the Securities and Exchange Commission on January 9 and declared effective on January 22. The offering http://www.streetinsider.com/Equity+Offerings/Immix+Biopharma+closes+%24150+million+stock+offering/26542843.html Fri, 22 May 2026 17:15:13 -0400 IMMX